NEUROPATHIC PAIN TREATMENTS | ||||
---|---|---|---|---|
Generic | Brand | Strength | Form | Adult Dose |
Alpha2-Delta Ligand | ||||
pregabalin | Lyrica | 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg |
caps | Diabetic Peripheral Neuropathy: Initially 50mg 3 times daily, may increase to 100mg 3 times daily within 1wk. Fibromyalgia: Initially 75mg twice daily, may increase to 150mg twice daily within 1 wk as tolerated; max 450mg/day. Postherpetic Neuralgia: Initially 75mg twice daily or 50mg 3 times daily; max 300mg/day after 1wk then 600mg/day after 2wks as tolerated. Spinal Cord Injury: Initially 75mg twice daily, may increase to 150mg twice daily in 1wk, then max 600mg/day after 2wks as tolerated. For all: Renal impairment: CrCl <60mL/min: Reduce dose (see full labeling); hemodialysis: Give supplemental dose after session. |
20mg/mL | oral soln | |||
Lyrica CR | 82.5mg, 165mg, 330mg |
ext-rel tabs | Diabetic Peripheral Neuropathy: Initially 165mg daily, may increase to max 330mg/day within 1wk. Postherpetic Neuralgia: Initially 165mg daily, may increase to 330mg daily within 1wk; max 660mg/day if insufficient relief after 2–4wks. For all: Renal impairment: CrCl 30–60mL/min: Reduce dose (see full labeling); CrCl <30mL/min or hemodialysis: Dose with Lyrica. |
|
L-Methylfolate | ||||
L-methyl– folate calcium/ algae-S powder/ pyridoxal 5-phos– phate/ methylco– balamin |
Metanx | 3mg/ 90.314mg/ 35mg/2mg |
caps | Diabetic Peripheral Neuropathy: 1 cap twice daily or 2 caps once daily |
Opioid Agonist | ||||
tapentadol | Nucynta ER |
50mg, 100mg, 150mg, 200mg, 250mg |
ext-rel tabs | Diabetic Peripheral Neuropathy: Usual dose: 100–250mg twice daily (approx. every 12hrs). Opioid-naïve or opioid non-tolerant: Initially 50mg twice daily; titrate to optimal dose. Max 500mg/day. Moderate hepatic impairment: Initially 50mg once every 24hrs; max 100mg/day. Withdraw gradually (esp. if opioid-dependent), taper by ≤10–25% every 2–4wks. |
Serotonin and Norepinephrine Reuptake Inhibitors (SNRI) | ||||
duloxetine HCl | Cymbalta | 20mg, 30mg, 60mg |
del-rel caps | Diabetic Peripheral Neuropathy: 60mg once daily; may start at lower doses if 60mg not tolerated. Renal impairment: Consider lower starting dose and slow titration Fibromyalgia: Initially 30mg once daily for 1wk, then increase to 60mg once daily. |
Drizalma Sprinkle | 20mg, 30mg, 40mg, 60mg |
del-rel caps | ||
milnacipran HCl | Savella | 12.5mg, 25mg, 50mg, 100mg |
tabs | Fibromyalgia: Day 1: 12.5mg once. Days 2−3: 12.5mg twice daily. Days 4−7: 25mg twice daily. After Day 7: 50mg twice daily (recommended dose); max 100mg twice daily. Severe renal impairment: CrCl 5−29mL/min: Maintenance 25mg twice daily; max 50mg twice daily. |
Topical Analgesics | ||||
capsaicin | Qutenza | 8% (179mg) | patch | Diabetic Peripheral Neuropathy, Postherpetic Neuralgia: Pretreat with topical anesthetic to reduce discomfort, once anesthetized, remove anesthetic and wash the treatment area. Apply to dry, intact skin within 2hrs of opening patch. Apply patch (up to 4 may be used) for 60mins (PHN) or 30mins (DPN), repeat every 3mos or as warranted by the return of pain (not more frequently than every 3mos). Treat acute pain during and following the procedure with local cooling and/or analgesics. |
Zostrix Original Strength | 0.033% | emol– lient crm |
Diabetic Peripheral Neuropathy, Postherpetic Neuralgia: Apply 3−4 times daily | |
Zostrix Maximum Strength | 0.1% | |||
lidocaine | Lidoderm | 5% | patch | Postherpetic Neuralgia: Apply to intact skin, covering most painful area. To adjust dose, cut patches before removing release liner. May apply up to 3 patches at once for up to 12hrs of a 24-hr period. Hepatic impairment or debilitated: use smaller treatment areas. |
Ztlido | 1.8% | |||
Others | ||||
gabapentin | Gralise | 300mg, 600mg |
tabs | Postherpetic Neuralgia: Take once daily with the evening meal. Initially 300mg on Day 1, 600mg on Day 2, 900mg on Days 3−6, 1200mg on Days 7−10, 1500mg on Days 11−14, titrate up to 1800mg on Day 15. Renal impairment: CrCl 30–60mL/min: 600–1800mg; CrCl <30mL/min or on hemodialysis: not recommended. |
Neurontin | 100mg, 300mg, 400mg |
caps | Postherpetic Neuralgia: 300mg once on day 1, twice daily on day 2, and 3 times daily on day 3; may titrate up to usual max 1.8g/day in 3 divided doses (doses up to 3.6g/day have been used without added benefit). Renal dysfunction: CrCl 30−59mL/min: 400−1400mg/day twice daily; CrCl 15−29mL/min: 200−700mg once daily; CrCl ≤15mL/min: 100−300mg once daily (see full labeling); hemodialysis: 125−350mg after session. | |
600mg, 800mg |
scored tabs | |||
250mg/5mL | soln | |||
gabapentin enacarbil | Horizant | 300mg, 600mg |
ext-rel tabs | Postherpetic Neuralgia: Initially 600mg in the AM for 3 days, then increase to 600mg twice daily beginning on Day 4 (no additional benefit seen with >1200mg daily dose). Renal impairment: CrCl 30−59mL/min: initially 300mg in the AM for 3 days, then 300mg twice daily; may increase to 600mg twice daily if needed or tolerated. CrCl 15−29mL/min: 300mg in the AM on Day 1 and Day 3, then continue with 300mg in AM; may increase to 300mg twice daily if needed. CrCl <15mL/min: Maintenance: 300mg every other day in the AM, may increase to 300mg once daily if needed. CrCl <15mL/min on hemodialysis: Maintenance: 300mg after every session, may increase to 600mg if needed. |
NOTES | ||||
Key: DPN = diabetic peripheral neuropathy; PHN = post-herpetic neuralgia (Rev. 3/2024) |
Please login or register first to view this content.